ENTRY LIMITING AGREEMENTS FOR PHARMACEUTICALS:Pay-for-Delay Agreements • November 3rd, 2013
Contract Type FiledNovember 3rd, 2013A pay-for-delay deal (or ‘reverse payment’) involves a payment from a branded drug manufacturer to a generic maker to delay market entry